New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
January 30, 2017 – AstraZeneca announced the FDA approval of Symbicort (budesonide/formoterol fumarate dehydrate), for the treatment of asthma in patients 6 years of age and older.
Download PDF
Return to publications
